Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Prokidney Corp (PROK)

Prokidney Corp (PROK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 507,492
  • Shares Outstanding, K 291,662
  • Annual Sales, $ 0 K
  • Annual Income, $ -35,470 K
  • EBIT $ -156 M
  • EBITDA $ -152 M
  • 60-Month Beta 1.11
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A

Options Overview Details

View History
  • Implied Volatility 188.06% ( +34.67%)
  • Historical Volatility 109.44%
  • IV Percentile 48%
  • IV Rank 19.25%
  • IV High 917.73% on 12/18/23
  • IV Low 14.08% on 07/15/24
  • Put/Call Vol Ratio 0.20
  • Today's Volume 6
  • Volume Avg (30-Day) 133
  • Put/Call OI Ratio 0.15
  • Today's Open Interest 2,114
  • Open Int (30-Day) 2,844

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -0.14
  • Number of Estimates 4
  • High Estimate -0.09
  • Low Estimate -0.19
  • Prior Year -0.09
  • Growth Rate Est. (year over year) -55.56%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.4900 +16.78%
on 11/04/24
2.2650 -23.18%
on 11/14/24
-0.1300 (-6.95%)
since 10/21/24
3-Month
1.4801 +17.56%
on 10/03/24
2.5700 -32.30%
on 09/19/24
-0.6500 (-27.20%)
since 08/21/24
52-Week
1.1800 +47.46%
on 02/13/24
4.4400 -60.81%
on 05/20/24
-0.1200 (-6.45%)
since 11/21/23

Most Recent Stories

More News
ProKidney Reports Third Quarter 2024 Financial Results along with Regulatory and Clinical Development Updates Following Successful FDA Type B Meeting

PROK : 1.7400 (+5.45%)
ProKidney to Participate in the Guggenheim Inaugural Healthcare Innovation Conference and the Jefferies London Healthcare Conference

PROK : 1.7400 (+5.45%)
ProKidney Announces Five Abstracts Selected for Presentation at the American Society of Nephrology’s Kidney Week 2024

PROK : 1.7400 (+5.45%)
ProKidney to Participate in the UBS Virtual Organ Restoration Day

PROK : 1.7400 (+5.45%)
Why Shares of ProKidney Were Dropping Thursday

Two factors led to the stock's slide on Thursday.

PROK : 1.7400 (+5.45%)
Pre-Market Brief: Stocks Mostly Higher As Investors Await U.S. Inflation Data

March S&P 500 futures (ESH23) are trending up +0.32% this morning after three major U.S. benchmark indices finished the regular session higher as market participants awaited U.S. inflation data for further...

ESH23 : 3,957.05s (-0.09%)
JD-.LN : 95.280 (-0.17%)
HEPA : 0.6900 (-0.62%)
BWEN : 1.5500 (unch)
PROK : 1.7400 (+5.45%)
CONN : 0.0975 (-46.40%)
SHC : 12.41 (-6.06%)
STM : 24.54 (+0.16%)
Did This News Just Mark the End of the SPAC Boom?

The most prolific SPAC sponsor just made a big announcement.

LCID : 2.06 (+1.48%)
DKNG : 43.55 (-0.57%)
SPCE : 6.72 (+0.60%)
OPEN : 1.7000 (+4.29%)
CLOV : 3.36 (+0.30%)
SOFI : 15.01 (+2.32%)
PROK : 1.7400 (+5.45%)
AKLI : 0.4320 (-0.62%)
IPOD : 10.03 (-0.10%)
IPOF : 10.03 (unch)
ProKidney Strengthens Board of Directors with Appointments of Dr. John M. Maraganore and Jennifer Fox

Maraganore brings more than 35 years of scientific, research and development, capital markets and managerial leadership expertise to ProKidney Fox joins...

PROK : 1.7400 (+5.45%)
ProKidney Appoints Kerry Cooper, M.D., as Senior Vice President of Medical Affairs

Extensive Nephrology Medical Affairs Leadership and Clinical Practice Expertise Brought to ProKidney...

PROK : 1.7400 (+5.45%)

Business Summary

ProKidney LP is a late clinical-stage cellular therapeutics company focused on CKD. The company's lead product candidate includes REACT(TM) is a first-of-its-kind, patented disease-modifying autologous cellular therapy. ProKidney LP, formerly known as Suvretta Holdings Corp. III, is based in WINSTON-SALEM,...

See More

Key Turning Points

3rd Resistance Point 1.9600
2nd Resistance Point 1.8800
1st Resistance Point 1.8100
Last Price 1.7400
1st Support Level 1.6600
2nd Support Level 1.5800
3rd Support Level 1.5100

See More

52-Week High 4.4400
Fibonacci 61.8% 3.1947
Fibonacci 50% 2.8100
Fibonacci 38.2% 2.4253
Last Price 1.7400
52-Week Low 1.1800

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar